We aim to provide autologous and allogeneic hematopioetic stem cell Transplantation (HSCT) for children with malignant and benign diseases. HSCT can be curative for genetic diseases such as thalassemia and sickle cell disease. We deploy alternative options for patients without matched donors, using haploidentical transplantion with specific techniques.